FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591368346> ?p ?o ?g. }

• W2591368346 abstract "Abstract Abstract 858 In normal hematopoiesis, only a small population of lin-Sca-1+c-kit+ (LSK) cells with Flt3-CD150+48− immunophenotype has long-term hematopoietic stem cell (LT-HSC) capacity, whereas Flt3-CD150+CD48+ and Flt3-CD150-CD48+ LSK cells represent more differentiated multipotent progenitors (MPP1 and MPP2) without long-term engrafting capacity. Despite extensive investigation into BCR-ABL induced leukemogenesis, the impact of BCR-ABL expression on LSK subpopulations and the specific subpopulation with leukemia-initiating capacity remain unknown. Targeted expression of the BCR-ABL gene in murine hematopoietic stem and progenitor cells (HSPC), using a Tet-regulated SCL promoter, results in development of a chronic phase CML-like disorder (Blood 105:.324, 2005). Mice consistently develop leukocytosis, splenomegaly and expansion of bone marrow (BM) myeloid progenitors and primitive LSK cells following induction of BCR-ABL expression. Here we employed the SCL-tTA-BCR/ABL mouse model to investigate the effect of BCR-ABL expression on HSPC populations. BCR/ABL expression resulted in a 3-fold increase in granulocyte-macrophage progenitors (GMP) and a 1.5-fold increase in LSK cell numbers compared with non-induced controls, whereas numbers of common myeloid progenitors (CMP) and megakaryocyte-erythrocyte progenitors (MEP) were reduced. Despite expansion of total LSK cells, the number of LT-HSC was markedly reduced in the BM of BCR-ABL expressing mice (610±246 vs. 4,038±982). In contrast, an increase in MPP1 (6,150±1,813 vs. 3,185±1,247) and MPP2 (39,580±14,079 vs. 25,115±7,090) was seen. BCR-ABL mRNA expression was confirmed in each population by RT-PCR, with highest levels of expression seen in MPP cells. In vivo EdU labeling demonstrated increased cycling of LSK cells from BCR/ABL expressing mice compared to controls. We observed a vast increase in the number of GMP (11-fold), CMP (10-fold), MPP (4.5 fold) and LT-HSC (2.5 fold) in the spleen of BCR/ABL mice compared to controls. Since the functional potential of HSPC cannot be determined solely on the basis of cell surface markers, we also studied the ability of transplanted populations to generate leukemia in recipient mice. SCL-tTA/BCR-ABL transgenic mice were crossed with GFP transgenic mice to facilitate tracking of transplanted cells. Only LSK cells, but not CMP or GMP, from BM and spleen of BCR-ABL expressing mice were capable of generating CML-like disease and long term engraftment (>16 weeks) in recipient mice. The leukemic phenotype of donors was recapitulated in recipient mice; and leukemia could be transplanted to secondary and tertiary recipients. Further analysis revealed that the subpopulation of cells with a LT-HSC phenotype (Flt3-CD150+CD48-) within the LSK population was capable of generating CML-like disease and long term engraftment in recipient mice. Consistent with the diminished LT-HSC numbers demonstrated by flow cytometry, the frequency of functional HSC within the LSK population, as measured by competitive repopulation limiting dilution assays, was reduced in BCR-ABL expressing mice (1 in 234) compared to control mice (1 in 14). Interestingly, not all transplanted mice with long-term engrafted BCR-ABL-expressing cells developed leukemia. We determined that 1 in 6 Flt3-CD150+CD48- LSK cells possessed repopulation activity, whereas only 1 in 80 cells was capable of initiating leukemia in transplanted mice within 20 weeks, indicating that only a subset of BCR-ABL+ cells with long-term repopulating potential has leukemia-initiating capacity. In summary, BCR-ABL expression is associated with significant reduction in LT-HSC and expansion of MPP and GMP in the BM, and a marked increase in LT-HSC, MPP, CMP and GMP in the spleen of transgenic mice. Reduced LT-HSC numbers in BM may be explained by increased proliferation of BCR-ABL-expressing HSC and their enhanced egress from the BM to extramedullary locations such as the spleen. BCR-ABL expressing LT-HSC demonstrated long term engraftment and secondary transplantation capacity. However, only a fraction of BCR-ABL-expressing long-term repopulating cells has leukemia-initiating capacity, suggesting that additional cell intrinsic or extrinsic factors besides BCR-ABL expression may play a role in determining their leukemogenic potential. Disclosures: No relevant conflicts of interest to declare." @default.
• W2591368346 created "2017-03-03" @default.
• W2591368346 creator A5010061250 @default.
• W2591368346 creator A5023363561 @default.
• W2591368346 creator A5035237919 @default.
• W2591368346 creator A5046881277 @default.
• W2591368346 creator A5055809371 @default.
• W2591368346 creator A5084224456 @default.
• W2591368346 date "2009-11-20" @default.
• W2591368346 modified "2023-09-30" @default.
• W2591368346 title "Characterization of Leukemia-Initiating Cells in a Transgenic Model of Chronic Phase Chronic Myelogenous Leukemia (CML)." @default.
• W2591368346 doi "https://doi.org/10.1182/blood.v114.22.858.858" @default.
• W2591368346 hasPublicationYear "2009" @default.
• W2591368346 type Work @default.
• W2591368346 sameAs 2591368346 @default.
• W2591368346 citedByCount "1" @default.
• W2591368346 crossrefType "journal-article" @default.
• W2591368346 hasAuthorship W2591368346A5010061250 @default.
• W2591368346 hasAuthorship W2591368346A5023363561 @default.
• W2591368346 hasAuthorship W2591368346A5035237919 @default.
• W2591368346 hasAuthorship W2591368346A5046881277 @default.
• W2591368346 hasAuthorship W2591368346A5055809371 @default.
• W2591368346 hasAuthorship W2591368346A5084224456 @default.
• W2591368346 hasConcept C109159458 @default.
• W2591368346 hasConcept C125418893 @default.
• W2591368346 hasConcept C196166836 @default.
• W2591368346 hasConcept C201750760 @default.
• W2591368346 hasConcept C203014093 @default.
• W2591368346 hasConcept C2776960273 @default.
• W2591368346 hasConcept C2778461978 @default.
• W2591368346 hasConcept C2778729363 @default.
• W2591368346 hasConcept C2779282312 @default.
• W2591368346 hasConcept C2779705218 @default.
• W2591368346 hasConcept C2780007613 @default.
• W2591368346 hasConcept C28328180 @default.
• W2591368346 hasConcept C2908647359 @default.
• W2591368346 hasConcept C42362537 @default.
• W2591368346 hasConcept C502942594 @default.
• W2591368346 hasConcept C553184892 @default.
• W2591368346 hasConcept C62478195 @default.
• W2591368346 hasConcept C71924100 @default.
• W2591368346 hasConcept C86803240 @default.
• W2591368346 hasConcept C95444343 @default.
• W2591368346 hasConcept C99454951 @default.
• W2591368346 hasConceptScore W2591368346C109159458 @default.
• W2591368346 hasConceptScore W2591368346C125418893 @default.
• W2591368346 hasConceptScore W2591368346C196166836 @default.
• W2591368346 hasConceptScore W2591368346C201750760 @default.
• W2591368346 hasConceptScore W2591368346C203014093 @default.
• W2591368346 hasConceptScore W2591368346C2776960273 @default.
• W2591368346 hasConceptScore W2591368346C2778461978 @default.
• W2591368346 hasConceptScore W2591368346C2778729363 @default.
• W2591368346 hasConceptScore W2591368346C2779282312 @default.
• W2591368346 hasConceptScore W2591368346C2779705218 @default.
• W2591368346 hasConceptScore W2591368346C2780007613 @default.
• W2591368346 hasConceptScore W2591368346C28328180 @default.
• W2591368346 hasConceptScore W2591368346C2908647359 @default.
• W2591368346 hasConceptScore W2591368346C42362537 @default.
• W2591368346 hasConceptScore W2591368346C502942594 @default.
• W2591368346 hasConceptScore W2591368346C553184892 @default.
• W2591368346 hasConceptScore W2591368346C62478195 @default.
• W2591368346 hasConceptScore W2591368346C71924100 @default.
• W2591368346 hasConceptScore W2591368346C86803240 @default.
• W2591368346 hasConceptScore W2591368346C95444343 @default.
• W2591368346 hasConceptScore W2591368346C99454951 @default.
• W2591368346 hasLocation W25913683461 @default.
• W2591368346 hasOpenAccess W2591368346 @default.
• W2591368346 hasPrimaryLocation W25913683461 @default.
• W2591368346 hasRelatedWork W1965619359 @default.
• W2591368346 hasRelatedWork W2252742661 @default.
• W2591368346 hasRelatedWork W2492610747 @default.
• W2591368346 hasRelatedWork W2549210377 @default.
• W2591368346 hasRelatedWork W2554130121 @default.
• W2591368346 hasRelatedWork W2555141618 @default.
• W2591368346 hasRelatedWork W2556632698 @default.
• W2591368346 hasRelatedWork W2557751752 @default.
• W2591368346 hasRelatedWork W2559189946 @default.
• W2591368346 hasRelatedWork W2560039739 @default.
• W2591368346 hasRelatedWork W2562798150 @default.
• W2591368346 hasRelatedWork W2564731311 @default.
• W2591368346 hasRelatedWork W2569683686 @default.
• W2591368346 hasRelatedWork W2572265095 @default.
• W2591368346 hasRelatedWork W2578264600 @default.
• W2591368346 hasRelatedWork W2582555189 @default.
• W2591368346 hasRelatedWork W2585399813 @default.
• W2591368346 hasRelatedWork W2588771628 @default.
• W2591368346 hasRelatedWork W3047237087 @default.
• W2591368346 hasRelatedWork W801242668 @default.
• W2591368346 isParatext "false" @default.
• W2591368346 isRetracted "false" @default.
• W2591368346 magId "2591368346" @default.
• W2591368346 workType "article" @default.